Compound Kushen Injection (CKI) is
Sophora Flavescens
and
Heterosmilacis Japonicae
extract. Meta-analysis
confirmed that CKI plus transcatheter arterial chemoembolization (TACE) is more superior to TACE alone for unresectable
hepatocellular carcinoma (UHCC) patients.